![Photo of Piotr Orzechowski](https://a.storyblok.com/f/120667/224x224/7b306107f0/piotr-orzechowski-grey.png/m/448x448/filters:format(webp))
![Infermedica 2023: Year in review](https://a.storyblok.com/f/120667/2400x1260/57cd433958/2023_review_og.jpg/m/4800x2520/filters:format(webp))
Infermedica 2023: Year in review
A reflection of Infermedica's achievements in 2023 and a look ahead to 2024.
![Infermedica raises $30 M in Series B funding](https://a.storyblok.com/f/120667/1200x630/5d152350a2/compass_og_img.jpeg/m/2400x1260/filters:format(webp))
Infermedica raises $30 M in Series B funding
We’re proud to announce another landmark occasion that enables Infermedica’s growth on a mission for better healthcare.
![Infermedica 2021: Year in Review](https://a.storyblok.com/f/120667/1200x630/7c9a172861/2021_a_year_in_review_1200.jpeg/m/2400x1260/filters:format(webp))
Infermedica 2021: Year in Review
A roundup of what we’ve accomplished in 2021, and what’s to come next year from Infermedica’s CEO, Piotr Orzechowski.
![Infermedica 2020: Year in review](https://a.storyblok.com/f/120667/1560x1100/e77dff90cd/2020_ilu_1560.png/m/3120x2200/filters:format(webp))
Infermedica 2020: Year in review
Infermedica navigated through 2020 and despite all obstacles, we kept supporting global healthcare to bring better health services. See what we achieved.
![Infermedica closes Series A funding with $10.25M](https://a.storyblok.com/f/120667/1200x630/b8183ed828/infermedica_funding_round_2020-og-image.jpg/m/2400x1260/filters:format(webp))
Infermedica closes Series A funding with $10.25M
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
![COVID-19 Risk Assessment tool is here](https://a.storyblok.com/f/120667/1584x970/074409f815/zawiesina-1.png/m/3168x1940/filters:format(webp))
COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
![COVID-19 and Infermedica](https://a.storyblok.com/f/120667/1584x1110/ebfe7285b3/covid19_blog.jpeg/m/3168x2220/filters:format(webp))
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
![Infermedica 2019: Year in Review](https://a.storyblok.com/f/120667/1200x630/15762adf1c/2019_year_in_review_image.png/m/2400x1260/filters:format(webp))
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
![Infermedica raises $3.65M in a new round of funding](https://a.storyblok.com/f/120667/1200x630/ff6b9aeb2f/og-infermedica-raises-funding.jpeg/m/2400x1260/filters:format(webp))
Infermedica raises $3.65M in a new round of funding
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.
![Infermedica 2018: Year in Review](https://a.storyblok.com/f/120667/1200x630/d7c550c341/infermedica-2018-year-in-review-og-image.png/m/2400x1260/filters:format(webp))
Infermedica 2018: Year in Review
With the new year upon us, I’d like to give you an update on 2018 activity and what to expect in 2019.
![We’ve moved Symptomate to the next level](https://a.storyblok.com/f/120667/1584x832/2da1bec606/og_2-1.png/m/3168x1664/filters:format(webp))
We’ve moved Symptomate to the next level
Infermedica’s CEO commends his team’s excellence and reveals enhancements to Symptomate.
![Infermedica 2017: Year in review](https://a.storyblok.com/f/120667/1584x960/74bc3bf4df/infermedica-year-in-review-2x-6.png/m/3168x1920/filters:format(webp))
Infermedica 2017: Year in review
Over three million diagnostic interviews conducted with patients. Amongst other changes at Infermedica in 2017.
![Illustration of a pigeon holding a letter](https://a.storyblok.com/f/120667/410x410/fc93bfd0ce/thank-you-pigeon-2x.png/m/1200x1200/filters:format(webp))